Know Cancer

or
forgot password
  • cancer clinical trials in bedford, TX

  • Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Non Small Cell Lung Cancer
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Texas Oncology,P.A.
    Bedford, Texas 76022
    Lymphoma, T-Cell, Peripheral
    PhII ICb With/Without Erbitux in MBC Pts
    Texas Oncology, P.A. - Bedford
    Bedford, Texas 76022
    Metastatic Breast Cancer
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Glioblastoma
    A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Texas Oncology, PA at Harris Center HEB
    Bedford, Texas 76022
    Prostate Cancer
    PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Non Hodgkin Lymphoma
    A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Non-Small Cell Lung Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Texas Oncology, P.A.-Bedford
    Bedford, Texas 76022
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Texas Oncology -Bedford
    Bedford, Texas 76022
    Breast Cancer
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    Texas Oncology, P.A. - Bedford
    Bedford, Texas 76022
    Metastatic Gastric or GEJ Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Texas Oncology, PA at Harris Center HEB
    Bedford, Texas 76022
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Phase II Sunitinib Prog Met AIPC
    Texas Oncology, P.A.-Bedford
    Bedford, Texas 76022
    Metastatic Prostate Cancer
    Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Non Small Cell Lung Cancer
    A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Non-small Cell Lung Cancer
    A Study of Nilotinib Versus Imatinib in GIST Patients
    Texas Oncology, P.A. Tex Onc (2)
    Bedford, Texas 76022
    Gastrointestinal Stromal Tumor (GIST)
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Texas Oncology, P.A. - Bedford
    Bedford, Texas 76022
    Urothelial Cancer
    A Study for Patients With Pancreatic Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Pancreatic Neoplasms
    Sunitinib Non Small Cell Lung Cancer Patients Over 70
    Texas Oncology, P.A. - Bedford
    Bedford, Texas 76022
    Non Small Cell Lung Cancer
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Texas Oncology PA - Bedford
    Bedford, Texas 76022
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    Edwards Cancer Center - Bedford

    Trial Locations
    Edwards Cancer Center - Bedford
    Texas Oncology PA - Harris HEB
    Breast Cancer
    A Study of Advanced or Metastatic Non-small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Non Small Cell Lung Cancer
    A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung
    Texas Oncology - Bedford
    Bedford, Texas 76022
    Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
    LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
    1199.15.10100 Boehringer Ingelheim Investigational Site
    Bedford, Texas
    Ovarian Neoplasms, Peritoneal Neoplasms
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #3
    Bedford, Texas 76022
    Metastatic Breast Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Texas Oncology - Bedford
    Bedford, Texas 76022
    Metastatic Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Texas Oncology, PA - Bedford
    Bedford, Texas 76022
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Texas Oncology, PA - Bedford
    Bedford, Texas 76022
    Multiple Myeloma
    A Study in Head and Neck Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Head and Neck Cancer
    A Phase 1 Study in Participants With Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck, Lung Squamous Cell Carcinoma Stage IV, Anal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung
    A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreated With Recurrent or Advanced Non-small Cell Lung Cancer (NSCLC)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Carcinoma, Non-Small-Cell Lung
    A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Participants Who Received Prior First Line Platinum Based Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Non Small Cell Lung Cancer
    A Study in Second Line Metastatic Colorectal Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Colorectal Cancer
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Rheumatoid Arthritis
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Texas Oncology - Bedford
    Bedford, Texas 76022
    Adenocarcinoma of the Lung
    A Study in Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Advanced Cancer
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Texas Oncology, PA at Harris Center HEB
    Bedford, Texas 76022
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Texas Oncology PA - Bedford
    Bedford, Texas 76022
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Carcinoma of Urinary Tract, Urethral Carcinoma, Carcinoma of Ureter, Carcinoma of Renal Pelvis
    A Safety Study in Patients With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Advanced Solid Tumors
    BKM120 as Second-line Therapy for Advanced Endometrial Cancer
    Texas Oncology, P.A. Austin
    Bedford, Texas 76022
    Advanced Endometrial Cancer
    A Phase 1 Study of LY2787106 in Cancer and Anemia
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Anemia
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    Texas Oncology, P.A. Austin

    Trial Locations
    Texas Oncology, P.A. Austin
    Texas Oncology, P.A. Tex Onc (3)
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    A Study of LY2523355 in Patients With Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Metastatic Breast Cancer
    A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
    Texas Oncology - Bedford
    Bedford, Texas 76022
    ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients
    A Study of LY2510924 in Patients With Extensive-Stage Small Cell Lung Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Extensive Stage Small Cell Lung Carcinoma
    Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
    Texas Oncology - Bedford
    Bedford, Texas 76022
    Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Solid Tumors
    A Study of LY3007113 in Participants With Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Metastatic Cancer
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Texas Oncology-Bedford
    Bedford, Texas 76022
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Pancreatic Cancer
    A Dose-Escalation Study in Participants With Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Advanced Cancer
    A Study in Recurrent Glioblastoma (GB)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Glioblastoma
    A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Neoplasms, Hematologic
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    Texas Oncology PA - Bedford
    Bedford, Texas 76022
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    A Study of IMC-TR1 in Patients With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bedford, Texas 76022
    Neoplasms, Tumor